

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of B cell differentiation (GO:0045579) | 5.95398257 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.43890284 |
| 3 | positive regulation of granulocyte differentiation (GO:0030854) | 5.07177209 |
| 4 | regulation of B cell differentiation (GO:0045577) | 4.99909647 |
| 5 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.89755677 |
| 6 | negative regulation of T-helper cell differentiation (GO:0045623) | 4.78882204 |
| 7 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 4.78882204 |
| 8 | seminiferous tubule development (GO:0072520) | 4.66565028 |
| 9 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.59572166 |
| 10 | regulation of female gonad development (GO:2000194) | 4.49076561 |
| 11 | mucosal-associated lymphoid tissue development (GO:0048537) | 4.48221009 |
| 12 | Peyers patch development (GO:0048541) | 4.48221009 |
| 13 | definitive hemopoiesis (GO:0060216) | 4.42876579 |
| 14 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.33423071 |
| 15 | B cell receptor signaling pathway (GO:0050853) | 4.11690483 |
| 16 | mature B cell differentiation involved in immune response (GO:0002313) | 4.09209260 |
| 17 | cellular response to exogenous dsRNA (GO:0071360) | 4.02051295 |
| 18 | negative regulation of granulocyte differentiation (GO:0030853) | 3.93573511 |
| 19 | regulation of granulocyte differentiation (GO:0030852) | 3.75971423 |
| 20 | dosage compensation (GO:0007549) | 3.74992424 |
| 21 | regulation of B cell apoptotic process (GO:0002902) | 3.64687134 |
| 22 | negative regulation of B cell apoptotic process (GO:0002903) | 3.60968720 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 3.55627649 |
| 24 | mast cell degranulation (GO:0043303) | 3.53914505 |
| 25 | mast cell activation involved in immune response (GO:0002279) | 3.53914505 |
| 26 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.53013220 |
| 27 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.53008795 |
| 28 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.49816282 |
| 29 | regulation of germinal center formation (GO:0002634) | 3.47735144 |
| 30 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.44003002 |
| 31 | positive thymic T cell selection (GO:0045059) | 3.42028694 |
| 32 | mast cell activation (GO:0045576) | 3.33980604 |
| 33 | immunoglobulin mediated immune response (GO:0016064) | 3.32429929 |
| 34 | negative thymic T cell selection (GO:0045060) | 3.29267546 |
| 35 | hepatocyte apoptotic process (GO:0097284) | 3.26275768 |
| 36 | lymphoid progenitor cell differentiation (GO:0002320) | 3.24559343 |
| 37 | mature B cell differentiation (GO:0002335) | 3.24203785 |
| 38 | autophagic vacuole fusion (GO:0000046) | 3.24166219 |
| 39 | cellular hyperosmotic response (GO:0071474) | 3.20009693 |
| 40 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.19958137 |
| 41 | response to peptidoglycan (GO:0032494) | 3.19748559 |
| 42 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.19503399 |
| 43 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 3.11860693 |
| 44 | purine nucleotide salvage (GO:0032261) | 3.11442004 |
| 45 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.08918258 |
| 46 | nucleotide salvage (GO:0043173) | 3.05691892 |
| 47 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.01234762 |
| 48 | organelle membrane fusion (GO:0090174) | 3.00986143 |
| 49 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 3.00703621 |
| 50 | response to hydroperoxide (GO:0033194) | 3.00300637 |
| 51 | L-fucose catabolic process (GO:0042355) | 3.00210205 |
| 52 | fucose catabolic process (GO:0019317) | 3.00210205 |
| 53 | L-fucose metabolic process (GO:0042354) | 3.00210205 |
| 54 | negative regulation of interleukin-17 production (GO:0032700) | 2.99445345 |
| 55 | negative T cell selection (GO:0043383) | 2.98677383 |
| 56 | B cell mediated immunity (GO:0019724) | 2.98609439 |
| 57 | histamine secretion (GO:0001821) | 2.95049643 |
| 58 | regulation of interleukin-17 production (GO:0032660) | 2.94128892 |
| 59 | interkinetic nuclear migration (GO:0022027) | 2.88232439 |
| 60 | alpha-beta T cell activation (GO:0046631) | 2.87682044 |
| 61 | positive regulation of B cell activation (GO:0050871) | 2.87608292 |
| 62 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.87587452 |
| 63 | response to host immune response (GO:0052572) | 2.87587452 |
| 64 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.87113821 |
| 65 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.86452841 |
| 66 | response to muramyl dipeptide (GO:0032495) | 2.85901721 |
| 67 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.83303023 |
| 68 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.83160423 |
| 69 | regulation of antigen processing and presentation (GO:0002577) | 2.77428214 |
| 70 | cellular response to dsRNA (GO:0071359) | 2.76118736 |
| 71 | regulation of chromatin silencing (GO:0031935) | 2.74867028 |
| 72 | regulation of B cell activation (GO:0050864) | 2.74096978 |
| 73 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.73652417 |
| 74 | positive regulation of antigen processing and presentation (GO:0002579) | 2.73516157 |
| 75 | negative regulation of interleukin-12 production (GO:0032695) | 2.72481731 |
| 76 | ribosomal small subunit assembly (GO:0000028) | 2.72401890 |
| 77 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.72190680 |
| 78 | B cell differentiation (GO:0030183) | 2.71512712 |
| 79 | positive T cell selection (GO:0043368) | 2.70684920 |
| 80 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.68009708 |
| 81 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.66866275 |
| 82 | viral transcription (GO:0019083) | 2.66632429 |
| 83 | megakaryocyte development (GO:0035855) | 2.66239320 |
| 84 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.65925163 |
| 85 | regulation of histone phosphorylation (GO:0033127) | 2.64679402 |
| 86 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.64477941 |
| 87 | response to host (GO:0075136) | 2.64477941 |
| 88 | response to host defenses (GO:0052200) | 2.64477941 |
| 89 | cellular extravasation (GO:0045123) | 2.64365669 |
| 90 | positive regulation of isotype switching (GO:0045830) | 2.64078605 |
| 91 | positive regulation of interleukin-17 production (GO:0032740) | 2.62139648 |
| 92 | regulation of erythrocyte differentiation (GO:0045646) | 2.62063791 |
| 93 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.60915828 |
| 94 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.60723369 |
| 95 | neutrophil activation involved in immune response (GO:0002283) | 2.58757706 |
| 96 | negative regulation of T cell mediated immunity (GO:0002710) | 2.58201688 |
| 97 | B cell activation (GO:0042113) | 2.58193082 |
| 98 | histone H3-K9 modification (GO:0061647) | 2.56014283 |
| 99 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.55292699 |
| 100 | pinocytosis (GO:0006907) | 2.55187065 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.29167620 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.57927086 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.09913504 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.83707243 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.38479441 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.35703421 |
| 7 | VDR_24763502_ChIP-Seq_THP-1_Human | 3.29050192 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.98321292 |
| 9 | MYB_26560356_Chip-Seq_TH2_Human | 2.94386412 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.88347671 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.79072978 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.67760081 |
| 13 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.67531909 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 2.63197509 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.54622946 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.53010545 |
| 17 | UTX_26944678_Chip-Seq_JUKART_Human | 2.35597287 |
| 18 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.34048673 |
| 19 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.29132578 |
| 20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.29111098 |
| 21 | MYB_26560356_Chip-Seq_TH1_Human | 2.28011493 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.27557286 |
| 23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.27190013 |
| 24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.24731911 |
| 25 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22697996 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.14173331 |
| 27 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.09887135 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.09801873 |
| 29 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.00308870 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 1.97123949 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.95275764 |
| 32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.89523302 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84588727 |
| 34 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.84234917 |
| 35 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.83633990 |
| 36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.82306964 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.82275205 |
| 38 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.81088081 |
| 39 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.80550132 |
| 40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.77295082 |
| 41 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.73093984 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.72892404 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.70719482 |
| 44 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.70465801 |
| 45 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.67807531 |
| 46 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.64106329 |
| 47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62063260 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.60591519 |
| 49 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.60158535 |
| 50 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.56269204 |
| 51 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.55928365 |
| 52 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.52846887 |
| 53 | GATA3_26560356_Chip-Seq_TH2_Human | 1.51482983 |
| 54 | MAF_26560356_Chip-Seq_TH2_Human | 1.50334896 |
| 55 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.49583359 |
| 56 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47643852 |
| 57 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.45669143 |
| 58 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.44918163 |
| 59 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42999983 |
| 60 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.42871041 |
| 61 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.41565674 |
| 62 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.39419808 |
| 63 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.30472241 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.30403971 |
| 65 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.29558348 |
| 66 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.27832248 |
| 67 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.25856068 |
| 68 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22969988 |
| 69 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.21607432 |
| 70 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.21565930 |
| 71 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.21194867 |
| 72 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18078853 |
| 73 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15749182 |
| 74 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15541383 |
| 75 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.13117580 |
| 76 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12053401 |
| 77 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.10989218 |
| 78 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.10846856 |
| 79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.08104710 |
| 80 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.07032835 |
| 81 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00836816 |
| 82 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.00361745 |
| 83 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.99621465 |
| 84 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99199139 |
| 85 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.96682449 |
| 86 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.96600976 |
| 87 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95985473 |
| 88 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.95050616 |
| 89 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.95024959 |
| 90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94781832 |
| 91 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.93636289 |
| 92 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90531411 |
| 93 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.90394484 |
| 94 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.89908297 |
| 95 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88728155 |
| 96 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.88663077 |
| 97 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.88471956 |
| 98 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87724513 |
| 99 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.85430226 |
| 100 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83833185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 5.71063362 |
| 2 | MP0009278_abnormal_bone_marrow | 3.95037746 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.78508759 |
| 4 | MP0005397_hematopoietic_system_phenotyp | 2.91059141 |
| 5 | MP0001545_abnormal_hematopoietic_system | 2.91059141 |
| 6 | MP0008057_abnormal_DNA_replication | 2.82566419 |
| 7 | MP0003436_decreased_susceptibility_to | 2.80983502 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.47587536 |
| 9 | MP0005464_abnormal_platelet_physiology | 2.44747994 |
| 10 | MP0005084_abnormal_gallbladder_morpholo | 2.32998938 |
| 11 | MP0001800_abnormal_humoral_immune | 2.28552040 |
| 12 | MP0004808_abnormal_hematopoietic_stem | 2.28261942 |
| 13 | MP0003763_abnormal_thymus_physiology | 2.23806017 |
| 14 | MP0006054_spinal_hemorrhage | 2.14949209 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.14399228 |
| 16 | MP0002398_abnormal_bone_marrow | 2.11036627 |
| 17 | MP0001819_abnormal_immune_cell | 2.10581210 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.10363500 |
| 19 | MP0000685_abnormal_immune_system | 2.09314069 |
| 20 | MP0001790_abnormal_immune_system | 2.06112323 |
| 21 | MP0005387_immune_system_phenotype | 2.06112323 |
| 22 | MP0003183_abnormal_peptide_metabolism | 2.03616087 |
| 23 | MP0001853_heart_inflammation | 2.01899464 |
| 24 | MP0008007_abnormal_cellular_replicative | 2.01841009 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.98991965 |
| 26 | MP0002723_abnormal_immune_serum | 1.98279744 |
| 27 | MP0002419_abnormal_innate_immunity | 1.94445231 |
| 28 | MP0002452_abnormal_antigen_presenting | 1.93355173 |
| 29 | MP0002009_preneoplasia | 1.87934802 |
| 30 | MP0000716_abnormal_immune_system | 1.81541090 |
| 31 | MP0005025_abnormal_response_to | 1.79886764 |
| 32 | MP0000689_abnormal_spleen_morphology | 1.73089092 |
| 33 | MP0005075_abnormal_melanosome_morpholog | 1.72815234 |
| 34 | MP0002722_abnormal_immune_system | 1.69604944 |
| 35 | MP0002405_respiratory_system_inflammati | 1.67857808 |
| 36 | MP0009785_altered_susceptibility_to | 1.67301258 |
| 37 | MP0008058_abnormal_DNA_repair | 1.58327377 |
| 38 | MP0002429_abnormal_blood_cell | 1.57787662 |
| 39 | MP0001986_abnormal_taste_sensitivity | 1.54989431 |
| 40 | MP0003303_peritoneal_inflammation | 1.53259227 |
| 41 | MP0005671_abnormal_response_to | 1.52769771 |
| 42 | MP0003787_abnormal_imprinting | 1.50209801 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.48652232 |
| 44 | MP0000703_abnormal_thymus_morphology | 1.47497643 |
| 45 | MP0002166_altered_tumor_susceptibility | 1.46078306 |
| 46 | MP0001873_stomach_inflammation | 1.42962278 |
| 47 | MP0003866_abnormal_defecation | 1.41842821 |
| 48 | MP0002822_catalepsy | 1.37362444 |
| 49 | MP0006292_abnormal_olfactory_placode | 1.33820757 |
| 50 | MP0000681_abnormal_thyroid_gland | 1.32054631 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.28809136 |
| 52 | MP0005220_abnormal_exocrine_pancreas | 1.28275393 |
| 53 | MP0009764_decreased_sensitivity_to | 1.27268257 |
| 54 | MP0010094_abnormal_chromosome_stability | 1.24711924 |
| 55 | MP0002006_tumorigenesis | 1.24499931 |
| 56 | MP0003806_abnormal_nucleotide_metabolis | 1.20380029 |
| 57 | MP0003828_pulmonary_edema | 1.14619287 |
| 58 | MP0009840_abnormal_foam_cell | 1.14100267 |
| 59 | MP0003786_premature_aging | 1.12477909 |
| 60 | MP0008877_abnormal_DNA_methylation | 1.11451006 |
| 61 | MP0002019_abnormal_tumor_incidence | 1.07450214 |
| 62 | MP0004947_skin_inflammation | 1.01803720 |
| 63 | MP0001845_abnormal_inflammatory_respons | 1.01078431 |
| 64 | MP0008469_abnormal_protein_level | 1.01077795 |
| 65 | MP0003943_abnormal_hepatobiliary_system | 1.00466663 |
| 66 | MP0009765_abnormal_xenobiotic_induced | 1.00455984 |
| 67 | MP0003300_gastrointestinal_ulcer | 0.94010019 |
| 68 | MP0003724_increased_susceptibility_to | 0.92785107 |
| 69 | MP0005174_abnormal_tail_pigmentation | 0.91476744 |
| 70 | MP0001533_abnormal_skeleton_physiology | 0.91459591 |
| 71 | MP0003252_abnormal_bile_duct | 0.90467242 |
| 72 | MP0008995_early_reproductive_senescence | 0.89087906 |
| 73 | MP0008875_abnormal_xenobiotic_pharmacok | 0.88658678 |
| 74 | MP0009379_abnormal_foot_pigmentation | 0.88058669 |
| 75 | MP0004782_abnormal_surfactant_physiolog | 0.84157493 |
| 76 | MP0009697_abnormal_copulation | 0.82402901 |
| 77 | MP0005451_abnormal_body_composition | 0.81261147 |
| 78 | MP0005319_abnormal_enzyme/_coenzyme | 0.77647156 |
| 79 | MP0009115_abnormal_fat_cell | 0.70234942 |
| 80 | MP0003191_abnormal_cellular_cholesterol | 0.69863348 |
| 81 | MP0008961_abnormal_basal_metabolism | 0.69767452 |
| 82 | MP0004185_abnormal_adipocyte_glucose | 0.68962960 |
| 83 | MP0003656_abnormal_erythrocyte_physiolo | 0.67779597 |
| 84 | MP0000858_altered_metastatic_potential | 0.66171331 |
| 85 | MP0002876_abnormal_thyroid_physiology | 0.62929982 |
| 86 | MP0010352_gastrointestinal_tract_polyps | 0.60695899 |
| 87 | MP0002138_abnormal_hepatobiliary_system | 0.59279117 |
| 88 | MP0009763_increased_sensitivity_to | 0.59187919 |
| 89 | MP0000598_abnormal_liver_morphology | 0.58293228 |
| 90 | MP0005390_skeleton_phenotype | 0.57806067 |
| 91 | MP0002998_abnormal_bone_remodeling | 0.57508846 |
| 92 | MP0002083_premature_death | 0.55245966 |
| 93 | MP0000313_abnormal_cell_death | 0.55191692 |
| 94 | MP0001881_abnormal_mammary_gland | 0.54443975 |
| 95 | MP0005535_abnormal_body_temperature | 0.52834209 |
| 96 | MP0006036_abnormal_mitochondrial_physio | 0.52371597 |
| 97 | MP0010307_abnormal_tumor_latency | 0.51647397 |
| 98 | MP0000383_abnormal_hair_follicle | 0.51097338 |
| 99 | MP0005266_abnormal_metabolism | 0.49862552 |
| 100 | MP0008873_increased_physiological_sensi | 0.49498729 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute lymphatic leukemia (HP:0006721) | 6.75109563 |
| 2 | Agammaglobulinemia (HP:0004432) | 6.67104445 |
| 3 | Abnormality of B cell number (HP:0010975) | 6.63372127 |
| 4 | B lymphocytopenia (HP:0010976) | 6.42823299 |
| 5 | Panhypogammaglobulinemia (HP:0003139) | 6.20275730 |
| 6 | Acute myeloid leukemia (HP:0004808) | 5.62252666 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.83527605 |
| 8 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.16429367 |
| 9 | Myositis (HP:0100614) | 3.73931622 |
| 10 | Recurrent viral infections (HP:0004429) | 3.70292393 |
| 11 | Thrombocytosis (HP:0001894) | 3.56309499 |
| 12 | Meningitis (HP:0001287) | 3.51970795 |
| 13 | Spondylolisthesis (HP:0003302) | 3.50845368 |
| 14 | Viral hepatitis (HP:0006562) | 3.46615970 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.33218951 |
| 16 | Cellulitis (HP:0100658) | 3.27537249 |
| 17 | Hypochromic microcytic anemia (HP:0004840) | 3.22056091 |
| 18 | Autoimmune hemolytic anemia (HP:0001890) | 3.21633138 |
| 19 | Polygenic inheritance (HP:0010982) | 3.17008686 |
| 20 | Encephalitis (HP:0002383) | 3.14979676 |
| 21 | Papilledema (HP:0001085) | 3.04178653 |
| 22 | Prolonged bleeding time (HP:0003010) | 3.02223095 |
| 23 | Abnormality of T cell physiology (HP:0011840) | 3.00017083 |
| 24 | Hypoplasia of the thymus (HP:0000778) | 2.97081582 |
| 25 | Gastrointestinal inflammation (HP:0004386) | 2.96290425 |
| 26 | Granulocytopenia (HP:0001913) | 2.94855465 |
| 27 | Colitis (HP:0002583) | 2.91618069 |
| 28 | Increased IgE level (HP:0003212) | 2.81802192 |
| 29 | Abnormality of the prostate (HP:0008775) | 2.74887411 |
| 30 | Stomatitis (HP:0010280) | 2.74262356 |
| 31 | Eosinophilia (HP:0001880) | 2.71351137 |
| 32 | Abnormality of T cells (HP:0002843) | 2.71025461 |
| 33 | Autoimmune thrombocytopenia (HP:0001973) | 2.70888584 |
| 34 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.63910292 |
| 35 | Recurrent cutaneous fungal infections (HP:0011370) | 2.63910292 |
| 36 | Osteomyelitis (HP:0002754) | 2.61669682 |
| 37 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.59811868 |
| 38 | Metaphyseal dysplasia (HP:0100255) | 2.59428505 |
| 39 | Inflammation of the large intestine (HP:0002037) | 2.56862565 |
| 40 | Stomach cancer (HP:0012126) | 2.55456295 |
| 41 | Chronic otitis media (HP:0000389) | 2.54510894 |
| 42 | Severe combined immunodeficiency (HP:0004430) | 2.47931995 |
| 43 | Hypergammaglobulinemia (HP:0010702) | 2.42150573 |
| 44 | Thyroiditis (HP:0100646) | 2.38927311 |
| 45 | Microvesicular hepatic steatosis (HP:0001414) | 2.38714821 |
| 46 | Abnormality of eosinophils (HP:0001879) | 2.34175969 |
| 47 | Leukocytosis (HP:0001974) | 2.31747941 |
| 48 | Verrucae (HP:0200043) | 2.30057402 |
| 49 | Papilloma (HP:0012740) | 2.30057402 |
| 50 | Renal cortical cysts (HP:0000803) | 2.29487864 |
| 51 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.22948807 |
| 52 | Thoracic kyphosis (HP:0002942) | 2.22562796 |
| 53 | Recurrent abscess formation (HP:0002722) | 2.22329636 |
| 54 | IgM deficiency (HP:0002850) | 2.19782792 |
| 55 | Alveolar cell carcinoma (HP:0006519) | 2.19560674 |
| 56 | Increased IgM level (HP:0003496) | 2.19544117 |
| 57 | Recurrent bacterial skin infections (HP:0005406) | 2.17330109 |
| 58 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.15798016 |
| 59 | Epistaxis (HP:0000421) | 2.13307678 |
| 60 | Mediastinal lymphadenopathy (HP:0100721) | 2.11443049 |
| 61 | Myelodysplasia (HP:0002863) | 2.09897569 |
| 62 | Increased intramyocellular lipid droplets (HP:0012240) | 2.09468115 |
| 63 | Abnormal hemoglobin (HP:0011902) | 2.08356490 |
| 64 | Neutropenia (HP:0001875) | 2.05773072 |
| 65 | Fatigue (HP:0012378) | 2.04963659 |
| 66 | Hypochromic anemia (HP:0001931) | 2.04474745 |
| 67 | Thickened calvaria (HP:0002684) | 2.02492195 |
| 68 | Increased cerebral lipofuscin (HP:0011813) | 2.01393318 |
| 69 | Sepsis (HP:0100806) | 2.01361854 |
| 70 | Dysostosis multiplex (HP:0000943) | 1.97821377 |
| 71 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.97071346 |
| 72 | Tubulointerstitial nephritis (HP:0001970) | 1.96176541 |
| 73 | Orchitis (HP:0100796) | 1.94778345 |
| 74 | Abnormality of T cell number (HP:0011839) | 1.93795000 |
| 75 | Interstitial pulmonary disease (HP:0006530) | 1.88878188 |
| 76 | Acute hepatic failure (HP:0006554) | 1.87050397 |
| 77 | T lymphocytopenia (HP:0005403) | 1.86808128 |
| 78 | Recurrent skin infections (HP:0001581) | 1.83681605 |
| 79 | Abnormality of male internal genitalia (HP:0000022) | 1.82391753 |
| 80 | Widely spaced teeth (HP:0000687) | 1.81748322 |
| 81 | Chronic obstructive pulmonary disease (HP:0006510) | 1.80912930 |
| 82 | Obstructive lung disease (HP:0006536) | 1.80912930 |
| 83 | Syringomyelia (HP:0003396) | 1.79571587 |
| 84 | Spinal cord lesions (HP:0100561) | 1.79571587 |
| 85 | Combined immunodeficiency (HP:0005387) | 1.79134950 |
| 86 | Pallor (HP:0000980) | 1.78871212 |
| 87 | Failure to thrive in infancy (HP:0001531) | 1.77835549 |
| 88 | Hepatitis (HP:0012115) | 1.77568826 |
| 89 | Chest pain (HP:0100749) | 1.76958428 |
| 90 | Increased muscle lipid content (HP:0009058) | 1.76303541 |
| 91 | Neurodegeneration (HP:0002180) | 1.72861687 |
| 92 | Decreased central vision (HP:0007663) | 1.72784273 |
| 93 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.72298722 |
| 94 | Vacuolated lymphocytes (HP:0001922) | 1.71430039 |
| 95 | Aplastic anemia (HP:0001915) | 1.70225664 |
| 96 | Recurrent lower respiratory tract infections (HP:0002783) | 1.69486733 |
| 97 | Abnormality of oral frenula (HP:0000190) | 1.69257022 |
| 98 | Vasculitis (HP:0002633) | 1.68925840 |
| 99 | Cutis marmorata (HP:0000965) | 1.67572047 |
| 100 | Skin rash (HP:0000988) | 1.67185423 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FLT3 | 6.38947001 |
| 2 | KIT | 5.88173510 |
| 3 | MAP4K1 | 3.72579866 |
| 4 | SCYL2 | 3.20455999 |
| 5 | TXK | 2.60562404 |
| 6 | PIK3CG | 2.54162545 |
| 7 | FES | 2.29412603 |
| 8 | CSF1R | 2.25939802 |
| 9 | TEC | 2.23402554 |
| 10 | BMPR2 | 2.20940460 |
| 11 | BCKDK | 2.15482757 |
| 12 | PRPF4B | 2.04311704 |
| 13 | BTK | 1.95032288 |
| 14 | RIPK4 | 1.93691629 |
| 15 | SYK | 1.85591541 |
| 16 | TBK1 | 1.85245005 |
| 17 | NUAK1 | 1.68517082 |
| 18 | TNK2 | 1.56695775 |
| 19 | CDK6 | 1.56116318 |
| 20 | TAOK3 | 1.53920836 |
| 21 | MAP2K3 | 1.51078057 |
| 22 | TESK2 | 1.46372882 |
| 23 | EEF2K | 1.43033917 |
| 24 | ERN1 | 1.42883447 |
| 25 | ZAP70 | 1.42163296 |
| 26 | ITK | 1.33160212 |
| 27 | MATK | 1.31539098 |
| 28 | MAP3K14 | 1.30806211 |
| 29 | MKNK1 | 1.19533412 |
| 30 | IKBKE | 1.19316296 |
| 31 | RPS6KB2 | 1.15194300 |
| 32 | HCK | 1.12054581 |
| 33 | BRD4 | 1.10303832 |
| 34 | JAK3 | 1.09487336 |
| 35 | LYN | 1.01347440 |
| 36 | IKBKB | 1.00719455 |
| 37 | LCK | 0.99444432 |
| 38 | GRK6 | 0.98947756 |
| 39 | CCNB1 | 0.97521750 |
| 40 | MKNK2 | 0.93747850 |
| 41 | CDK12 | 0.92275885 |
| 42 | DAPK1 | 0.92046519 |
| 43 | HIPK2 | 0.91625408 |
| 44 | PIK3CA | 0.81927671 |
| 45 | BMPR1B | 0.79867312 |
| 46 | KDR | 0.72670662 |
| 47 | PIM1 | 0.72349537 |
| 48 | IRAK1 | 0.71646282 |
| 49 | PKN2 | 0.69395332 |
| 50 | VRK2 | 0.65438165 |
| 51 | EIF2AK3 | 0.65098656 |
| 52 | MAP3K11 | 0.64743572 |
| 53 | TRPM7 | 0.64089153 |
| 54 | MARK3 | 0.62237094 |
| 55 | CDK4 | 0.62163489 |
| 56 | MAPKAPK3 | 0.59901066 |
| 57 | LRRK2 | 0.57395627 |
| 58 | CHUK | 0.57183895 |
| 59 | JAK1 | 0.57085361 |
| 60 | CDK9 | 0.56705703 |
| 61 | MAP3K5 | 0.55856619 |
| 62 | IRAK4 | 0.54414340 |
| 63 | TGFBR1 | 0.52810990 |
| 64 | PRKCQ | 0.51294490 |
| 65 | ATR | 0.50652739 |
| 66 | MAPK3 | 0.50061529 |
| 67 | CDK8 | 0.49640796 |
| 68 | MAPK12 | 0.49406144 |
| 69 | PRKD2 | 0.47353874 |
| 70 | ABL1 | 0.42739784 |
| 71 | EIF2AK2 | 0.41517963 |
| 72 | DYRK1B | 0.38452814 |
| 73 | PASK | 0.35904044 |
| 74 | MAPK11 | 0.35201270 |
| 75 | RPS6KA4 | 0.32807419 |
| 76 | RPS6KL1 | 0.31032953 |
| 77 | RPS6KC1 | 0.31032953 |
| 78 | MAPK7 | 0.30971030 |
| 79 | MAPKAPK5 | 0.30584089 |
| 80 | TAOK2 | 0.29940327 |
| 81 | IGF1R | 0.28289138 |
| 82 | JAK2 | 0.28071799 |
| 83 | RPS6KA6 | 0.27638283 |
| 84 | MAPK1 | 0.25904977 |
| 85 | PBK | 0.25285943 |
| 86 | MAPKAPK2 | 0.25268721 |
| 87 | ACVR1B | 0.25162332 |
| 88 | MELK | 0.24827157 |
| 89 | STK39 | 0.24812028 |
| 90 | NME1 | 0.24762106 |
| 91 | TYK2 | 0.24307071 |
| 92 | SIK3 | 0.24223836 |
| 93 | TIE1 | 0.23965294 |
| 94 | AKT3 | 0.23735711 |
| 95 | IRAK3 | 0.23450978 |
| 96 | CDK7 | 0.23394264 |
| 97 | UHMK1 | 0.22974966 |
| 98 | DYRK3 | 0.22620507 |
| 99 | MAP3K7 | 0.21778680 |
| 100 | MAPK4 | 0.21635414 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.20915750 |
| 2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.07364926 |
| 3 | Asthma_Homo sapiens_hsa05310 | 2.76858109 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.55389421 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.43117030 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.35660671 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 2.24221839 |
| 8 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.15458696 |
| 9 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.13845572 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.06822753 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.04156650 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.00718229 |
| 13 | DNA replication_Homo sapiens_hsa03030 | 1.94399831 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.92874512 |
| 15 | Homologous recombination_Homo sapiens_hsa03440 | 1.91671187 |
| 16 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.88479538 |
| 17 | Ribosome_Homo sapiens_hsa03010 | 1.88439857 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.87822255 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.86538792 |
| 20 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.83174423 |
| 21 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.72598265 |
| 22 | Platelet activation_Homo sapiens_hsa04611 | 1.57914471 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.50879113 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.48915485 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.41557214 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.41482702 |
| 27 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.40979779 |
| 28 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.39775220 |
| 29 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.39716889 |
| 30 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.36948727 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.25647156 |
| 32 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.24783921 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.22746721 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17424235 |
| 35 | Mismatch repair_Homo sapiens_hsa03430 | 1.15318119 |
| 36 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.13852262 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.12663417 |
| 38 | Measles_Homo sapiens_hsa05162 | 1.10560954 |
| 39 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.08282874 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.06004083 |
| 41 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.02886037 |
| 42 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.01833147 |
| 43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.01790392 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.01771687 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.98490495 |
| 46 | Spliceosome_Homo sapiens_hsa03040 | 0.98172359 |
| 47 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.96422695 |
| 48 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.96246806 |
| 49 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.95976538 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 0.95148900 |
| 51 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.93619510 |
| 52 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.91815497 |
| 53 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.91182901 |
| 54 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.89663737 |
| 55 | Phototransduction_Homo sapiens_hsa04744 | 0.88827346 |
| 56 | Legionellosis_Homo sapiens_hsa05134 | 0.83404805 |
| 57 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.83372479 |
| 58 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.83343959 |
| 59 | Hepatitis B_Homo sapiens_hsa05161 | 0.83279903 |
| 60 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.82550077 |
| 61 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.82323259 |
| 62 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.75861931 |
| 63 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.74599419 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.73409757 |
| 65 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.73187919 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73070966 |
| 67 | Malaria_Homo sapiens_hsa05144 | 0.69895305 |
| 68 | Shigellosis_Homo sapiens_hsa05131 | 0.67801259 |
| 69 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.67288506 |
| 70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.66377772 |
| 71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.63182067 |
| 72 | Purine metabolism_Homo sapiens_hsa00230 | 0.62033055 |
| 73 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.61597304 |
| 74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.61421187 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59192791 |
| 76 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.59123958 |
| 77 | RNA degradation_Homo sapiens_hsa03018 | 0.58843008 |
| 78 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.58168616 |
| 79 | Peroxisome_Homo sapiens_hsa04146 | 0.54583503 |
| 80 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.54515969 |
| 81 | Hepatitis C_Homo sapiens_hsa05160 | 0.54109640 |
| 82 | RNA polymerase_Homo sapiens_hsa03020 | 0.53432779 |
| 83 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.50264964 |
| 84 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50080431 |
| 85 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48761247 |
| 86 | Lysine degradation_Homo sapiens_hsa00310 | 0.48419355 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46956569 |
| 88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46177425 |
| 89 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.45873295 |
| 90 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43201819 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.40848908 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39532092 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38768666 |
| 94 | RNA transport_Homo sapiens_hsa03013 | 0.38353500 |
| 95 | Pertussis_Homo sapiens_hsa05133 | 0.36036855 |
| 96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.33292530 |
| 97 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.32155596 |
| 98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30027761 |
| 99 | Apoptosis_Homo sapiens_hsa04210 | 0.28894122 |
| 100 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.28671488 |

